Contract Manufacturer Supplement

A supplement contract manufacturer is a Part 111-registered facility that manufactures dietary supplements under another firm's brand. Typical scope: ingredient receipt, identity and component testing, weighing, blending, encapsulation / tableting / softgel / liquid-fill, packaging, finished-product testing, holding, and shipping under the brand owner's label. Most US supplement volume is produced by contract manufacturers — not by brand-owned plants. The largest contract manufacturers (NOW Foods, Nutraceutix, Pharmavite, Glanbia, Vitaquest, Capsugel-now-Lonza, etc.) run hundreds of OLD relationships simultaneously.

21 CFR 111.12(a) puts the obligation on the own-label distributor; the rule does not relieve the contract manufacturer of Part 111 — every Part 111 subpart applies to whoever is performing the operation. The result is that for any given lot, both the CM and the OLD are responsible for the same compliance outcome through different mechanisms: the CM through actual execution, the OLD through oversight, qualification, and accountability. FDA can and does cite both parties for the same observation. A well-run CM understands this structurally and builds the brand-owner relationship into the compliance system — not around it.

FDA's 2016 Quality Agreements guidance is the operational gold standard. The agreement should: identify both parties, define product scope, allocate each Part 111 subpart's tasks (a RACI matrix is the cleanest mechanism), define audit rights and frequency, define batch-record access and retention, define complaint and AE flow-down SLAs, define change-control approvals, define recall coordination, and define termination and record-handover. The agreement is signed by both parties' QC heads and is itself a controlled document under change control.

A supplement contract manufacturer's per-brand support load is dominated by document handling: MMRs to maintain (one per SKU per brand), executed BPR copies to send (one per lot per brand), CoAs to issue, complaint and AE notifications to escalate, and quality-agreement updates to negotiate. A CM with 50 brand customers running 4 SKUs each runs 200 active MMRs and ships thousands of executed BPR PDFs per year. Manual handling of that workflow does not scale — and is itself a frequent source of compliance failure (lost MMRs, late AE escalation, BPR sent to wrong brand). Modern CMs therefore invest in MES + brand-portal infrastructure that automates the bilateral document flow, both for compliance and for margin.

• No quality agreement with one or more brand customers — both parties cited.
• MMR changes made without brand sign-off — the manufacturer's QC approved a substitution that the brand never saw.
• Identity test outsourced to an unqualified lab without the brand being informed — the brand assumed in-house testing.
• AE received and held at the CM without escalation to the brand — DSNDCPA 15-business-day clock blown by the time the brand learns of it.
• Stability OOS investigated and closed by the CM without brand involvement — brand learns at the next quarterly review.
• Reserve sample retention failure — neither party physically holds the §111.83 retention sample.
• Cross-contamination between brand A and brand B sharing a line — line clearance and changeover validation gaps.
• Label artwork managed by the brand outside the CM's change-control loop — printed label does not match approved MMR.

A defensible brand-side supplier-qualification programme for a CM includes: (1) document review (cGMP licence, facility registration, NSF/NPA/USP certifications, recent FDA Establishment Inspection Report if available, insurance, financials), (2) on-site or remote audit against a Part 111 checklist (Subparts A–P), (3) sample-lot Quality Agreement red-line, (4) trial-lot manufacture with extended-spec testing, (5) signed Quality Agreement, and (6) annual re-audit cadence. A CM that systematically prepares for this cycle — audit-ready document binders, transparent FDA history, pre-prepared quality-agreement template — wins more brand business and shortens the qualification time from 9 months to 3.

• Tenant type 'contract_manufacturer' enables multi-brand routing throughout the system (every WO carries a brand_id alongside the formula).
• Brand portal: per-customer scoped MMR / BPR / CoA / complaint / AE feed.
• Quality Agreement register with version control and per-product scope.
• Bilateral SLA tracker for complaint and AE escalation (CM → brand acknowledgement clock).
• Brand-side e-sig step on BPR release before SHIPPED status is reached.
• Cross-brand changeover and line-clearance workflow with mandatory documentation for shared equipment.
• Label-artwork version control linked to MMR — brand cannot change artwork without re-approving MMR.